 |
 |
 |
|
Forgiveness of Antiretroviral Regimens: In Vitro HIV-1 Viral Breakthrough with 2-Drug versus 3-Drug Regimens Simulating Variable Adherence to Treatment
|
|
|
Reported by Jules Levin
10th IAS Conference on HIV Science (IAS 2019), 21-24 July 2019, Mexico City, Mexico
Andrew Mulato, Rima Acosta, Stephen R. Yant, Tomas Cihlar, and Kirsten White
Gilead Sciences, Inc., Foster City, CA, USA








|
|
|
 |
 |
|
|